Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
The International Journal of Biological Markers|February 13, 2016
Drafting biological material transfer agreement: a ready-to-sign model for biobanks and biorepositoriesSilvia Cervo, Paolo De Paoli, Ermes Mestroni, et al.Pathology, Research and Practice|March 15, 2016
Triple synchronous invasive malignancies of the female genital tract in a patient with a history of leukemia: A case report and review of the literatureBenito Chiofalo, Jacopo Di Giuseppe, Lara Alessandrini, et al.BMC Cancer|September 23, 2015
An improved sequencing-based strategy to estimate locus-specific DNA methylationGiulia Brisotto, Alessandra di Gennaro, Valentina Damiano, et al.BMC Medical Ethics|August 1, 2013
An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobankSilvia Cervo, Jane Rovina, Renato Talamini, et al.Leukemia & Lymphoma|September 17, 2011
In situ follicular lymphoma associated with nonlymphoid malignanciesAntonino Carbone, Maria Grazia Tibiletti, Vincenzo Canzonieri, et al.Disease Markers|November 9, 2005
MUC gene abnormalities in sporadic and hereditary mucinous colon cancers with microsatellite instabilityChiara Pastrello, Manuela Santarosa, Mara Fornasarig, et al.The Journal of Molecular Diagnostics : JMD|October 28, 2004
RT-PCR analysis of RNA extracted from Bouin-fixed and paraffin-embedded lymphoid tissuesAnnunziata Gloghini, Barbara Canal, Ulf Klein, et al.Oncotarget|January 13, 2017
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsMassimiliano Berretta, Carla Cavaliere, Lara Alessandrini, et al.Radiology and Oncology|March 2, 2013
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studiesAlessandro Tuzi, Davide Lombardi, Diana Crivellari, et al.Journal of Materials Chemistry. B|March 8, 2023
Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapyKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.Pageof 7